A CDC panel decided to end the universal birth dose of a hepatitis B vaccine for newborns, with some officials pointing to ...

The panel may vote to change the hepatitis B birth dose recommendation.

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

Americans’ confidence in the Centers for Disease Control and Prevention has plummeted, according to a 2025 National ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for ...

Fewer people have gotten vaccinated against respiratory illnesses this season vs. last, according to survey data presented by ...

Vaccines for pregnant women will be targeted for extra scrutiny by the vaccine safety advisory panel to the Centers for Disease Control and Prevention, a development that could lead to a change in ...

On the campaign trail last October, President Trump promised to let his health secretary, Robert F. Kennedy Jr., “go wild on ...